RTGN (RetinalGenix Technologies) Moat Score: 3/10 (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RTGN RetinalGenix Technologies Inc RTGN
30 GF Score
Price $4.00
! 1 Warning Sign
View Full Analysis

What is RetinalGenix Technologies Moat Score?

RetinalGenix Technologies RTGN +25.00% 30 Moat Score is 3 as of Aug. 15, 2026. GuruFocus rates RTGN with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

RetinalGenix Technologies has the Moat Score of 3, which implies that the company might have No Moat - Very weak/transient advantages.

RetinalGenix Technologies has No Moat: RetinalGenix Technologies Inc has some intellectual property in the medical field, but faces significant competition and lacks strong brand strength or customer loyalty. The absence of durable cost advantages or regulatory barriers limits its moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes RetinalGenix Technologies might have No Moat - Very weak/transient advantages.

RetinalGenix Technologies  (OTCPK:RTGN) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

RetinalGenix Technologies Moat Score Related Terms

RTGN vs SNWV, NNOX, LNSR: Moat Score Comparison

For the Medical Devices subindustry, RetinalGenix Technologies's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RetinalGenix Technologies Moat Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, RetinalGenix Technologies's Moat Score distribution charts can be found below:

* The bar in red indicates where RetinalGenix Technologies's Moat Score falls into.


RTGN
30GF Score
RetinalGenix Technologies Inc RTGN
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 3 mean?
RetinalGenix Technologies (RTGN) has a Moat Score of 3 as of Aug. 15, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.
Is RetinalGenix Technologies' Moat Score too high?
RetinalGenix Technologies' current Moat Score is 3. Overall, RetinalGenix Technologies has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does RetinalGenix Technologies' Moat Score compare to SNWV and NNOX?
RetinalGenix Technologies' Moat Score of 3 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Devices & Instruments company?
A good Moat Score depends on the Medical Devices & Instruments industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. RetinalGenix Technologies's current Moat Score is 3. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RetinalGenix Technologies stock overvalued right now?
RetinalGenix Technologies (RTGN) has a current Moat Score of 3. The current Moat Score is 3. RetinalGenix Technologies' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For RetinalGenix Technologies (RTGN), the current Moat Score is 3 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RetinalGenix Technologies Business Description

Address 409 Apollo Beach Boulevard, Suite 6, Apollo Beach, FL, USA, 33572
RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: Retinal Imaging Screening Device a portable, retinal imaging system providing a wide field of view without requiring pupil dilation; and RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available.
30GF Score

Get the complete analysis for RTGN

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.00
Price